P520: PHASE 1/2 STUDY OF SEL24/MEN1703, A FIRST‐IN‐CLASS DUAL PIM/FLT3 KINASE INHIBITOR, IN PATIENTS WITH IDH1/2‐MUTATED ACUTE MYELOID LEUKEMIA: THE DIAMOND‐01 TRIAL

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 6; pp. 419 - 420
Main Authors Martinelli, G., Santoro, A., Gambacorti‐Passerini, C., Vives Polo, S., Solomon, S. R., Mukherjee, S., Lech‐Maranda, E., Yair Levy, M., Wierzbowska, A., Calbacho‐Robles, M., Marconi, G., Benedetta Giannini, M., Cano, I., Torres Miñana, L., Acuña‐Cruz, E., Angelosanto, N., Galleu, A., Baldini, S., Blotta, S., Ravandi, F., Montesinos, P.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 01.06.2022
Wiley
Online AccessGet full text

Cover

Author Benedetta Giannini, M.
Galleu, A.
Baldini, S.
Gambacorti‐Passerini, C.
Martinelli, G.
Acuña‐Cruz, E.
Angelosanto, N.
Torres Miñana, L.
Cano, I.
Calbacho‐Robles, M.
Blotta, S.
Wierzbowska, A.
Santoro, A.
Marconi, G.
Yair Levy, M.
Vives Polo, S.
Ravandi, F.
Lech‐Maranda, E.
Solomon, S. R.
Mukherjee, S.
Montesinos, P.
Author_xml – sequence: 1
  givenname: G.
  surname: Martinelli
  fullname: Martinelli, G.
  organization: IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”‐IRST S.r.l
– sequence: 2
  givenname: A.
  surname: Santoro
  fullname: Santoro, A.
  organization: Humanitas Research Hospital
– sequence: 3
  givenname: C.
  surname: Gambacorti‐Passerini
  fullname: Gambacorti‐Passerini, C.
  organization: University of Milano‐Bicocca
– sequence: 4
  givenname: S.
  surname: Vives Polo
  fullname: Vives Polo, S.
  organization: Institut Català d'Oncologia‐Hospital Germans Trias i Pujol
– sequence: 5
  givenname: S. R.
  surname: Solomon
  fullname: Solomon, S. R.
  organization: Northside Hospital Cancer Institute
– sequence: 6
  givenname: S.
  surname: Mukherjee
  fullname: Mukherjee, S.
  organization: Cleveland Clinic
– sequence: 7
  givenname: E.
  surname: Lech‐Maranda
  fullname: Lech‐Maranda, E.
  organization: Institute of Hematology and Transfusion Medicine
– sequence: 8
  givenname: M.
  surname: Yair Levy
  fullname: Yair Levy, M.
  organization: Texas Oncology‐Baylor Charles A. Sammons Cancer Center
– sequence: 9
  givenname: A.
  surname: Wierzbowska
  fullname: Wierzbowska, A.
  organization: Medical University of Lodz
– sequence: 10
  givenname: M.
  surname: Calbacho‐Robles
  fullname: Calbacho‐Robles, M.
  organization: Ramón y Cajal University Hospital
– sequence: 11
  givenname: G.
  surname: Marconi
  fullname: Marconi, G.
  organization: IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” ‐ IRST S.r.l
– sequence: 12
  givenname: M.
  surname: Benedetta Giannini
  fullname: Benedetta Giannini, M.
  organization: IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” ‐ IRST S.r.l
– sequence: 13
  givenname: I.
  surname: Cano
  fullname: Cano, I.
– sequence: 14
  givenname: L.
  surname: Torres Miñana
  fullname: Torres Miñana, L.
  organization: La Fe University Hospital
– sequence: 15
  givenname: E.
  surname: Acuña‐Cruz
  fullname: Acuña‐Cruz, E.
– sequence: 16
  givenname: N.
  surname: Angelosanto
  fullname: Angelosanto, N.
  organization: Ryvu Therapeutics
– sequence: 17
  givenname: A.
  surname: Galleu
  fullname: Galleu, A.
  organization: Menarini Group
– sequence: 18
  givenname: S.
  surname: Baldini
  fullname: Baldini, S.
  organization: Menarini Group
– sequence: 19
  givenname: S.
  surname: Blotta
  fullname: Blotta, S.
  organization: Menarini Group
– sequence: 20
  givenname: F.
  surname: Ravandi
  fullname: Ravandi, F.
  organization: The University of Texas MD Anderson Cancer Center
– sequence: 21
  givenname: P.
  surname: Montesinos
  fullname: Montesinos, P.
  organization: La Fe University Hospital
BookMark eNqVkU1u1EAQhS0UJELIHVqsM57-83T37Dp2G7fin9G4LZRVy2630URDjOxIKDuOwBE4AYfgKJwEJ4OALbWoeirV-2rxXgdn9-O9D4K3CIYICraGKMxqEcKlOKViw0MaEYpD0r8IznHE8Epgis7-0a-Cy3m-W-6REGKD2XnwfRdhuAW7TNYKoDUGtWmSW1CloFY5putClYhBcgUkSPW-Nj-_fNXl0uJc1jVIGpmDnS7WaW7Ij283unzC6DLT19pU-6tFgp00WpWmBu-1yYBOsuXLAigaI41KgIwbo0Bxq_JKJyBXzY0qtNwCkymQaFlUZbJcQwTMXsv8TfByaI-zv_w9L4ImVSbOVnn1TscyXzmMRbQiHuGhbznvKBs6J0THWcS9IxxiN8Co3xDiu44Pjke9gC1jvScdaxHuOKe4IxeBPnH7sb2zn6bDx3Z6tGN7sM-Lcfpg2-nh4I7eOkdZz1skGBso933nEHOUYO-R6wcoFtb2xHLTOM-TH_7wELRPQVqI7BKk_RukfQ7Skn4xxyfz58PRP_6H02aqINcpJIxF5BcO0J17
ContentType Journal Article
Copyright Copyright © 2022 The Author(s).
Copyright_xml – notice: Copyright © 2022 The Author(s).
DBID 24P
WIN
AAYXX
CITATION
DOA
DOI 10.1097/01.HS9.0000844968.45342.3d
DatabaseName Wiley Open Access
Wiley Online Library Journals
CrossRef
Directory of Open Access Journals
DatabaseTitle CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
EISSN 2572-9241
EndPage 420
ExternalDocumentID oai_doaj_org_article_cc47d8a1977f48edbc17c432ee1cdf09
10_1097_01_HS9_0000844968_45342_3d
HEM3BF03775
Genre abstract
GroupedDBID 0R~
24P
53G
AAAAV
AAHPQ
AASCR
ABASU
ABDIG
ABVCZ
ACGFS
ACILI
ACXJB
ADBBV
ADGGA
ADHPY
ADPDF
AFDTB
AFKRA
AHQNM
AHVBC
AINUH
AJIOK
AJNWD
AJZMW
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
BCNDV
BENPR
CCPQU
DIWNM
EBS
EEVPB
FCALG
GNXGY
GQDEL
GROUPED_DOAJ
HLJTE
HYE
IKREB
M~E
OK1
OPUJH
OVD
OVDNE
OVEED
OXXIT
PIMPY
RLZ
RPM
TEORI
TSPGW
WIN
AAYXX
CITATION
BQLVK
ID FETCH-LOGICAL-c2295-3e12fda88b47fbc99b8758ec3802cf05d633ebb8fc85d90a77de3b7a12b8842b3
IEDL.DBID DOA
ISSN 2572-9241
IngestDate Tue Oct 22 15:12:42 EDT 2024
Fri Aug 23 02:20:55 EDT 2024
Sat Aug 24 00:56:32 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License Attribution-NonCommercial-NoDerivs
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2295-3e12fda88b47fbc99b8758ec3802cf05d633ebb8fc85d90a77de3b7a12b8842b3
OpenAccessLink https://doaj.org/article/cc47d8a1977f48edbc17c432ee1cdf09
PageCount 2
ParticipantIDs doaj_primary_oai_doaj_org_article_cc47d8a1977f48edbc17c432ee1cdf09
crossref_primary_10_1097_01_HS9_0000844968_45342_3d
wiley_primary_10_1097_01_HS9_0000844968_45342_3d_HEM3BF03775
PublicationCentury 2000
PublicationDate June 2022
PublicationDateYYYYMMDD 2022-06-01
PublicationDate_xml – month: 06
  year: 2022
  text: June 2022
PublicationDecade 2020
PublicationPlace Philadelphia, PA
PublicationPlace_xml – name: Philadelphia, PA
PublicationTitle HemaSphere
PublicationYear 2022
Publisher Lippincott Williams & Wilkins
Wiley
Publisher_xml – name: Lippincott Williams & Wilkins
– name: Wiley
SSID ssj0001999627
Score 2.2338328
SourceID doaj
crossref
wiley
SourceType Open Website
Aggregation Database
Publisher
StartPage 419
SummonAdditionalLinks – databaseName: Wiley Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NjtMwFLZg2LBBIEAMf_KC5aSNfxI7IzaZNlEMSVs1iZhZRbZjz66DhmHPETgCJ-AQHIWTYLudVrNggdhEURS_p-Tzsz-_xN8D4J2USZZQoyLJJYsoVzySiVIR0qllWmc0CVUUmkVa9fTDeXK-2x7t98Js9SH2CTcfGWG89gEu1ZfpQTw2RpOqzYL-IKc0S_mEJoTiCRnvgwdeQsYr6WO6OmRcPLcPNVxdN8WRW3igWxVSr-L4V3N3Zqwg7H-XyIaZqHwMHu0oJMy3mD8B98zmKfi5SnB8CldV3hYQTTH0VO8CLkvYFjWm06ZYIBd2JzCHpVi33e9v38XCHWZ13rZw3uc1XIlmWtYd-fXDLem9GbGoxJnolusTdwpXeSeKRdfCT6KroJhXzosz0PRd7kY_mM_6roDNRVEvxRzWRf_RIZyfwq4q4Fx44ZS5uztGsFuLvH4G-rLoZlW0q8UQaV_wOyIGYTtKzhVlVuksU26hw40mPMbaxsmYEmKU4lbzZMxiydhoiGISYcU5xYo8B0ebq415AeDIDPM8xXEvS41VyrJ0pNJmqUWZSbNjQG7f9_B5K7kx7D-Vo8GhNBxQGgJKAxmPwZmHZt_Cy2aHC1fXl8MuCgetKRu5RI70WsrNqDRimhJsDNKjjZ3r9wHYf_A7VEVD_G_07ple_l_zV-Ah9psrQo7nNTi6uf5q3jjKc6Pehp78B_Ds578
  priority: 102
  providerName: Wiley-Blackwell
Title P520: PHASE 1/2 STUDY OF SEL24/MEN1703, A FIRST‐IN‐CLASS DUAL PIM/FLT3 KINASE INHIBITOR, IN PATIENTS WITH IDH1/2‐MUTATED ACUTE MYELOID LEUKEMIA: THE DIAMOND‐01 TRIAL
URI https://onlinelibrary.wiley.com/doi/abs/10.1097%2F01.HS9.0000844968.45342.3d
https://doaj.org/article/cc47d8a1977f48edbc17c432ee1cdf09
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9MwGLZgXLggECDGoPKB49zGH4mdiUvWuIohaasmge0UxV_HgtD4SfxP7LQb2wkhcbMsOf54XtvP69jPC8CHcUzzlDmNRjFyxIQWaEy1RthknhuTs3SKotCss6pnn67Sq3uhvuKdsIM88GHgFsYwbsWIA0_xTDirDeaGUeIcNtYfn-4l-T1najpdiTye8FuV0ajSiOdVm09yhYKxPBNzllJG5tQ-2JEm4f6HRHXaaVbPwbMjRYTFoWkvwCO3fwl-bVOSXMBtVbQS4gWBkcpdw80KtrImbNHINQ7T6hwWcKV2bYfUGi3rom1h2Rc13Kpmsao7CoO3Hr-g1pW6VN1mdx6ScFt0Sq67Fn5VXQVVWYUKUNN3RVjWYLHsOwmba1lvVAlr2X8O0BUXsKskLFVURClRgmG3U0X9CvQr2S0rdAyxgEyM442ow8TbUQjNuNcmz3XwX4QzVCTE-CS1GaVOa-GNSG2ejJxbRzUfMdFCMKLpa3Cy_7Z3bwC03PFIPwKl8sx5rT3PLBt9nnmcuyw_BfR2mIfvByWN4e4POB4COMMfcIYJnIHaU3AZEbkrEdWwp4xgI8PRRoa_2cgp-Djh-Q_1DpVsaLwdH_r09n-04Qw8JfHlxHSA8w6c3Pz46d4HPnOjZ-AxYdvZZMAz8GTzRcryN-S94eU
link.rule.ids 315,783,787,867,2109,11574,27936,27937,46064,46488
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3LbtQwFLVKWcAGgQBRnl6wbGbiRxKnYpPOJIppkhlNHNGuotix2U1RVfZ8Ap_AF_ARfApfgu15qQsWiE0URfG9So6vfXwTnwvA-2GI0ohqGQxsSALKJAuGSMoAqdgkSqU08lUU6iYuO_rxMro8AvVuL8xGH2KfcHOR4cdrF-AuIT09qMeGaFK2qRcgZJSmMZvQiFA8IeM9cJ_Gtmc6oWe6PKRcHLn3RVxtP8WBXXmgnQypk3H8q7k7U5ZX9r_LZP1UVDwGj7YcEmYb0J-AI71-Cn4uIxyewWWZtTlEUwwd17uCiwK2eYXptM4bZOPuFGaw4KtW_P72nTf2MKuytoXzLqvgktfTohLk1w-7pndmeFPycy4Wq1N7CpeZ4HkjWviJixLyeWm9WAN1JzI7_MFs1okc1ld5teBzWOXdhYU4O4OizOGcO-WUub07RFCseFY9A12Ri1kZbIsxBMpV_A6IRtiMA2OSJkaqNJV2pcO0IizEyoTRGBOipWRGsWhMwyFJRk1kMiAsGaNYkufgeH291i8AHBOdOKJiyZeh2khpknikg0ljg1IdpyeA7N53_2WjudHvv5Wj3qLUH1DqPUo9GU_AuYNm38LpZvsL1zef-20Y9krRZGQDsqzXUKZHqVCiKMFaIzWa0Lr-4IH9B799mdfE_Udvn-nl_zV_Bx6Uoq76ijcXr8BD7HZa-ITPa3B8e_NVv7H851a-9b36D68f6zM
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1NbtQwFLagSIgNAgGiUMALls1M_JPEqdikk0QxTTLRJBHtKor_2E2rqt1zBI7ACTgER-Ek2JnpjLpggdhEURS_p-Tzsz-_xN8D4OM4BnFAtfBGNkYeZYJ5YyCEh2RoIiljGkxVFKo6LHr6-Tw4326PdnthNvoQu4Sbi4xpvHYBfqXMfC8e66NZ0caT_iCjNA7ZjAaE4hlRD8Ejanm5U9LHtNlnXBy3n2q42m6KPbvwQHcqpE7F8a_m7s1Yk7D_fSI7zUT5M_B0SyFhssH8OXig1y_AzybA_glsiqTNIJpj6KjeBVzmsM1KTOdVViMbdscwgTlftd3vb995bQ-LMmlbmPZJCRtezfOyI79-2CW9M8Prgp_ybrk6tqewSTqe1V0Lv_CugDwtrBdroOq7xI5-MFn0XQari6xc8hSWWX9mEU5OYFdkMOVOOCW1d_sIdiuelC9Bn2fdovC2tRg86Qp-e0QjbNTImKCRETKOhV3oMC0J87E0fqBCQrQQzEgWqNgfo0hpIqIRYcEYxYK8Agfry7V-DaCKdOR4iuVehmojhIlCRUcThwbFOowPAbl738PVRnJj2H0qR4NFadijNEwoDUQdglMHza6Fk82eLlxefx22UThISSPFRmRJr6FMKyFRJCnBWiOpjG9df5qA_Qe_Q5FVxP1Gb5_pzf81_wAeN2k-lLw-ewueYLfPYkr3HIGDm-tb_c6ynxvxfurUfwATAupT
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=P520%3A+PHASE+1%2F2+STUDY+OF+SEL24%2FMEN1703%2C+A+FIRST-IN-CLASS+DUAL+PIM%2FFLT3+KINASE+INHIBITOR%2C+IN+PATIENTS+WITH+IDH1%2F2-MUTATED+ACUTE+MYELOID+LEUKEMIA%3A+THE+DIAMOND-01+TRIAL&rft.jtitle=HemaSphere&rft.au=G.+Martinelli&rft.au=A.+Santoro&rft.au=C.+Gambacorti-Passerini&rft.au=S.+Vives+Polo&rft.date=2022-06-01&rft.pub=Wiley&rft.eissn=2572-9241&rft.volume=6&rft.spage=419&rft.epage=420&rft_id=info:doi/10.1097%2F01.HS9.0000844968.45342.3d&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_cc47d8a1977f48edbc17c432ee1cdf09
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2572-9241&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2572-9241&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2572-9241&client=summon